February 5, 2020 / 1:22 PM / 15 days ago

BRIEF-Aimmune Therapeutics Announces Additional $200 Mln Equity Investment By Nestlé Health Science

Feb 5 (Reuters) - Aimmune Therapeutics Inc:

* AIMMUNE THERAPEUTICS ANNOUNCES ADDITIONAL $200 MILLION EQUITY INVESTMENT BY NESTLÉ HEALTH SCIENCE

* AIMMUNE THERAPEUTICS INC - WEDNESDYA’S INVESTMENT BRINGS NESTLÉ’S TOTAL INVESTMENT IN AIMMUNE TO DATE TO $473 MILLION

* AIMMUNE THERAPEUTICS - UPON CLOSING OF INVESTMENT, CO TO RECEIVE $200 MILLION WITH NESTLÉ HEALTH SCIENCE BUYING 1 MILLION NEWLY ISSUED SHARES OF CO

* AIMMUNE THERAPEUTICS - AFTER COMPLETION, NESTLÉ HEALTH SCIENCE’S TOTAL INVESTMENTS IN CO WILL CORRESPOND TO 19.9% OF CO’S OUTSTANDING STOCK & VOTING POWER Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below